Enzymes, the core catalysts in life, drive critical biological processes ranging from metabolic regulation to energy ...
Johnson & Johnson will invest $55 billion in the U.S. over the next four years. The announcement comes a month after Eli ...
The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
Cocaine production in South America is surging, and much of that is being found and seized at the U.S.-Mexico border.
Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.
The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...
Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacture — a key step in bringing new drugs to ...
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS' Saint-Beauzire site ...
Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.